Showing results (491-500 of 5,042) with videos related to

Sort By:
Pageof 505
Multiple Sclerosis and Related Disorders|February 4, 2019
Erythroblast appearance associated with natalizumabYuya Kobayashi, Ryota Takamatsu, Shunichi Sato, et al.
Multiple Sclerosis and Related Disorders|November 27, 2018
Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesisIeva Eskyte, Ana Manzano, George Pepper, et al.
Multiple Sclerosis and Related Disorders|October 27, 2019
Do people with multiple sclerosis want to discuss their long-term prognosis? A nationwide study in ArgentinaEdgar Carnero Contentti, Pablo A López, Juan Pablo Pettinicchi, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Interleukin 1 receptor antagonist and 2'-5'-oligoadenylate synthetase-like molecules as novel biomarkers for multiple sclerosis patients in BahrainMoudi Al-Nashmi, Safa Taha, Isa Alsharoqi, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Cerebral toxoplasmosis in an MS patient receiving FingolimodAlejandro Enriquez-Marulanda, Jaime Valderrama-Chaparro, Laura Parrado, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Information processing deficits as a driving force for memory impairment in MS: A cross--sectional study of memory functions and MRI in early and late stage MSWolfgang Köhler, Martin Fischer, Peter Bublak, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Validity and reliability of the International Cooperative Ataxia Rating Scale (ICARS) and the Scale for the Assessment and Rating of Ataxia (SARA) in multiple sclerosis patients with ataxiaYeliz Salcı, Ayla Fil, Hilal Keklicek, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
High dose biotin as treatment for progressive multiple sclerosisGary Birnbaum, Jessica Stulc
Multiple Sclerosis and Related Disorders|November 17, 2017
Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendationsMohammad Ali Sahraian, Abdorreza Naser Moghadasi, Amir Reza Azimi, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
"Nail loss after teriflunomide treatment: A new potential adverse event"L Mancinelli, P Amerio, M di Ioia, et al.
Pageof 505